Bailard’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-9,633
| Closed | -$728K | – | 806 |
|
|
2026
Q1 | $728K | Buy |
9,633
+1
| +0% | +$75 | 0.02% | 413 |
|
|
2025
Q4 | $717K | Sell |
9,632
-5,913
| -38% | -$432K | 0.02% | 393 |
|
|
2025
Q3 | $1.05M | Buy |
15,545
+2
| +0% | +$133 | 0.02% | 326 |
|
|
2025
Q2 | $1.01M | Sell |
15,543
-224
| -1% | -$13.4K | 0.02% | 321 |
|
|
2025
Q1 | $974K | Sell |
15,767
-6
| -0% | -$398 | 0.03% | 309 |
|
|
2024
Q4 | $1.14M | Buy |
15,773
+36
| +0.2% | +$2.81K | 0.03% | 283 |
|
|
2024
Q3 | $1.28M | Sell |
15,737
-747
| -5% | -$59.7K | 0.03% | 272 |
|
|
2024
Q2 | $1.22M | Sell |
16,484
-20
| -0.1% | -$1.5K | 0.03% | 268 |
|
|
2024
Q1 | $1.29M | Sell |
16,504
-528
| -3% | -$39.3K | 0.04% | 270 |
|
|
2023
Q4 | $1.22M | Buy |
17,032
+14
| +0.1% | +$975 | 0.04% | 266 |
|
|
2023
Q3 | $1.18M | Sell |
17,018
-4,772
| -22% | -$361K | 0.04% | 247 |
|
|
2023
Q2 | $1.76M | Sell |
21,790
-13,964
| -39% | -$1.14M | 0.06% | 207 |
|
|
2023
Q1 | $2.89M | Sell |
35,754
-1,950
| -5% | -$157K | 0.1% | 162 |
|
|
2022
Q4 | $2.82M | Buy |
37,704
+20,817
| +123% | +$1.48M | 0.11% | 157 |
|
|
2022
Q3 | $1.09M | Buy |
16,887
+4,537
| +37% | +$314K | 0.05% | 237 |
|
|
2022
Q2 | $856K | Buy |
+12,350
| New | +$917K | 0.03% | 264 |
|
Other funds holding HOLX
Bailard's HOLX Position: Q2 2026 in Review
Bailard sold out of Hologic (HOLX) in Q2 2026, closing a stake of 9,633 shares — an estimated $728K sold.
Bailard first reported a position in HOLX in Q2 2022 and held it in 16 quarters. The position peaked at $2.89M in Q1 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Bailard reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Bailard sold 9,633 Hologic shares in Q2 2026, an estimated $728K.
- Bailard first reported a position in Hologic in Q2 2022 and held it in 16 quarters.
- Bailard's Hologic position peaked at $2.89M in Q1 2023.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.